Related Experiment Video

Updated: Jun 4, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Pandemic (H1N1) 2009-associated pneumonia in children, Japan

Maki Hasegawa1, Takafumi Okada, Hiroshi Sakata

  • 1Kitasato University, Tokyo, Japan.

Emerging Infectious Diseases
|February 5, 2011
PubMed

Insights

Pandemic (H1N1) 2009 virus-associated pneumonia in children typically resulted in full recovery, with most patients hospitalized for a median of 6 days. Early hospital access appeared to improve outcomes for pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Public health

Background:

  • The 2009 pandemic influenza A (H1N1) virus caused significant respiratory illness globally.
  • Pneumonia is a serious complication of influenza, particularly in children.
  • Understanding the clinical course of H1N1-associated pneumonia in pediatric populations is crucial for effective management.

Purpose of the Study:

  • To detail the clinical characteristics of children diagnosed with pandemic (H1N1) 2009 virus-associated pneumonia.
  • To identify the incidence of complications and factors associated with outcomes in these pediatric patients.

Main Methods:

  • Retrospective study of 80 children admitted to 5 Japanese hospitals between August and November 2009 with confirmed H1N1 pneumonia.
  • Data collection included time from symptom onset to hospital admission, presence of complications, and hospitalization duration.
  • Analysis of clinical outcomes, focusing on recovery and any identified complications.

Main Results:

  • Eighty children were studied, with a mean of 2.9 days from symptom onset to admission.
  • 17% of the children experienced complications during their illness.
  • All patients recovered, with a median hospitalization of 6 days.

Conclusions:

  • Pandemic (H1N1) 2009 virus-associated pneumonia in children generally has a favorable prognosis.
  • Prompt medical attention and hospital admission appear to be associated with positive outcomes.
  • Further research into specific complications and management strategies is warranted.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...